Helen Albert is a Senior Editor who specializes in precision medicine and biotechnology. Her work has been featured in publications such as Inside Precision Medicine, Labiotech.eu, and Chemistry World. She covers a wide range of topics including breakthrough therapies, diagnostic advancements, and the intersection of technology and healthcare.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Helen's coverage is predominantly focused on healthcare and pharmaceuticals, with an emphasis on scientific breakthroughs. Her articles frequently cite data, indicating a preference for evidence-based reporting.
Given the technical and research-oriented nature of her articles, Helen would likely be interested in sources who can provide expert insights into cutting-edge medical research or technological advancements within the healthcare and pharmaceutical sectors.
Articles featuring biotech movies suggest she could also be open to human-interest pieces related to the industry. However, it's essential that pitches align with her focus on scientific and evidence-based content.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Helen Albert
Mailing tests to people who need screening can help increase colorectal cancer test uptake rates in low-income communities.
Having a genetic predisposition to insulin deficiency and abnormal fat distribution around the body may explain why South Asian people seem to be
By: Helen Albert
Research in mice suggests that genetic mutations in the SLC25A1 gene, which plays a role in placental development, could be behind some congenital heart defects.
The presence of a specific type of fat, known as visceral fat, in midlife can predict risk for Alzheimer's disease in later years, according to research led by Washington University School of Medicine.
A tiny missing piece of the protein CPEB4, which moves around the cell and helps regulate gene expression, can impact neuronal activity and results in symptoms of autism spectrum disorder.
Cancer is one of the first areas where precision medicine was applied in a clinical setting. Today, particularly in developed countries such as the U.S. and U.K., it is becoming increasingly common to undergo precision diagnostic testing and subsequent targeted therapy depending on the tumor mutations and type of cancer. It is widely acknowledged that […]
Research led by the Cleveland Clinic has identified specific groups of microglia linked to Alzheimer's disease as well as the genes driving the disease transition.
By: Helen Albert
People with mantle cell lymphoma (MCL) who go into remission after initial therapy may not need an autologous stem cell transplant, a procedure that tends to be recommended for people with this type of cancer.
A candidate mRNA treatment for early-stage pre-eclampsia , which treats abnormal blood vessels in the placenta, has achieved good results in a mouse model.
Lack of funding and infrastructure in the region has made it hard to establish local programs in Africa in the past, but things are changing. Genomics and the early stages of precision medicine are now being set up in a number of countries on the continent.
(833) 317-6278 
